Delta variant is expected to rapidly outcompete other variants and become the dominant variant over the coming months
03 Jul 2021 11:07 AM
The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases
03 Jul 2021 10:50 AM